Minimum Required Vitamin D Level for Optimal Increase in Bone Mineral Density with Alendronate Treatment in Osteoporotic Women
β Scribed by Muneaki Ishijima; Yuko Sakamoto; Makoto Yamanaka; Akifumi Tokita; Keiichiro Kitahara; Haruka Kaneko; Hisashi Kurosawa
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 224 KB
- Volume
- 85
- Category
- Article
- ISSN
- 1432-0827
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Anabolic treatment with teriparatide of postmenopausal osteoporotic patients previously treated with bisphosphonates is a new therapeutic approach. However, its effects on the bone mineralization density distribution (BMDD) are unknown. We studied paired transiliac bone biopsy samples t
We examined the association of bone mineral density (BMD) with a polymorphism in the gene encoding the vitamin D receptor (VOR) that causes a change in the predicted protein sequence. The polymorphism results from a C-to-T transition and creates an initiation codon (ATG) three codons proximal to a d